Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
05 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/new-england-journal-of-medicine-publishes-results-of-global-multicenter-enrgy-study-evaluating-zenocutuzumab-zbco-bizengri-in-nrg1-cancer-302369431.html
09 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/barda-and-partner-therapeutics-continue-partnership-around-development-of-leukine-sargramostim-rhu-gm-csf-to-potentially-improve-patient-care-for-sepsis-302347356.html
03 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/partner-therapeutics-leukine-sargramostim-receives-approval-in-japan-to-treat-autoimmune-pulmonary-alveolar-proteinosis-apap-302107763.html
17 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/comprehensive-review-highlights-importance-of-leukine-in-combination-with-anti-gd2-immunotherapy-for-treatment-of-high-risk-pediatric-neuroblastoma-302037532.html
20 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/exploratory-results-suggest-the-potential-role-of-leukine-as-a-host-directed-immunomodulator-302020419.html
15 Dec 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/partner-therapeutics-announces-publication-of-a-retrospective-cohort-review-of-15-leukine-treated-patients-with-pediatric-malignancies-and-invasive-fungal-disease-refractory-to-antifungal-therapy-301704560.html
ABOUT THIS PAGE
Partner Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Hydroxy Echinocandin bulk with DMF offered by Partner Therapeutics